Srinivas Vourganti to Middle Aged
This is a "connection" page, showing publications Srinivas Vourganti has written about Middle Aged.
Connection Strength
0.451
-
Assessing the diagnostic performance of systematic freehand PrecisionPoint transperineal prostate biopsy: Comparison of observed outcomes to PBCG nomogram predictions. Urol Oncol. 2022 01; 40(1):4.e9-4.e17.
Score: 0.076
-
Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2?years too long to wait? Nephrol Dial Transplant. 2017 Oct 01; 32(10):1767-1773.
Score: 0.058
-
Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 2012 Dec; 188(6):2152-2157.
Score: 0.041
-
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol. 2022 08 01; 8(8):1128-1136.
Score: 0.020
-
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
Score: 0.015
-
End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomes. Urol Oncol. 2017 08; 35(8):529.e1-529.e7.
Score: 0.014
-
The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols. Urol Oncol. 2017 04; 35(4):153.e15-153.e20.
Score: 0.014
-
Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells. J Urol. 2016 Apr; 195(4 Pt 1):1136-42.
Score: 0.013
-
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol. 2015 Apr; 33(4):167.e13-20.
Score: 0.012
-
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int. 2015 Mar; 115(3):381-8.
Score: 0.012
-
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol. 2014 Jul-Aug; 20(4):293-8.
Score: 0.012
-
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol. 2014 May-Jun; 20(3):234-8.
Score: 0.011
-
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014 Feb 10; 32(5):431-7.
Score: 0.011
-
MRI characterization of the dynamic effects of 5a-reductase inhibitors on prostate zonal volumes. Can J Urol. 2013 Dec; 20(6):7002-7.
Score: 0.011
-
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. 2013 Sep 15; 119(18):3359-66.
Score: 0.011
-
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol. 2013 Dec; 190(6):2020-2025.
Score: 0.011
-
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013 Nov; 64(5):713-719.
Score: 0.011
-
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013 Nov; 190(5):1721-1727.
Score: 0.011
-
Estrogen receptor-? expression and pharmacological targeting in bladder cancer. Oncol Rep. 2013 Jul; 30(1):131-8.
Score: 0.011
-
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014 Jan; 32(1):23.e9-13.
Score: 0.010
-
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int. 2012 Dec; 110(11 Pt B):E783-8.
Score: 0.010
-
Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol. 2012 Dec; 188(6):2084-8.
Score: 0.010
-
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int. 2012 Dec; 110(11):1642-7.
Score: 0.010
-
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 2012 Jun; 109(11):1600-6.
Score: 0.010
-
Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples. Urology. 2011 Sep; 78(3):601-5.
Score: 0.009
-
A Pfannenstiel single-site nephrectomy and nephroureterectomy: a practical application of laparoendoscopic single-site surgery. Urology. 2009 Sep; 74(3):482-5.
Score: 0.008
-
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 2003 Mar 01; 63(5):965-71.
Score: 0.005
-
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration. Blood. 2002 Oct 01; 100(7):2341-8.
Score: 0.005